{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:22:24Z","timestamp":1793413344980,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral squamous cell carcinoma is a global threat and accounts for approximately 90% of malignant oral lesions. The emergence of oral carcinoma is linked to precancerous lesions, which act as precursors of the disease. Matrix metalloproteinases appear to play a significant role in the pathogenesis of both precancerous conditions and oral malignancies due to their participation in remodeling of the extracellular matrix.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>This is an analytical study conducted at Dow University of Health Sciences, Pakistan. Unstimulated saliva samples were collected from healthy, oral submucous fibrosis and oral squamous cell carcinoma patients. The level of MMP-12 was estimated using enzyme-linked immunosorbent assay. One-way Analysis of variance was run to determine if MMP-12 levels differ between the three groups, which was preceded by post hoc Tuckey test. MMP-12 cut off values were determined using Receiver operating characteristic curve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A significant difference in salivary MMP-12 expression was observed in OSF and OSCC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The expression of salivary MMP-12 was higher in OSF and OSCC patients as compared to the healthy group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The mean MMP-12 expression in OSCC appeared higher than in OSF cases (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). MMP-12 value of\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$\\ge$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mo>\u2265<\/mml:mo>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      4.05\u00a0ng\/ml and\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$\\ge$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mo>\u2265<\/mml:mo>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      4.20\u00a0ng\/ml is predictive of OSF and OSCC respectively, with 100% sensitivity and specificity (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Increased expression of MMP-12 appears as the healthy patient advances to OSF and OSCC. The study results also demonstrate higher MMP-12 expression in OSCC patients as compared to OSF. Therefore, the estimation of salivary MMP-12 serves as a valuable non-invasive early diagnostic tool in diagnosing oral submucous fibrosis and oral squamous cell carcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-021-01571-7","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T12:03:15Z","timestamp":1619179395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Zohra","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Hafeez","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Mansoor","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas Ahmed","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"issue":"1","key":"1571_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12903-020-01362-6","volume":"21","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhou M, Zeng X, Wang C. The burden of oral cancer in China, 1990\u20132017: an analysis for the Global Burden of Disease, Injuries, and Risk Factors Study 2017. BMC Oral Health. 2021;21(1):1\u201311.","journal-title":"BMC Oral Health"},{"issue":"3","key":"1571_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.32413\/pjph.v8i3.97","volume":"8","author":"Z Saleem","year":"2018","unstructured":"Saleem Z, Abbas SA, Nadeem F, Majeed MM. The habits and reasons of delayed presentation of patients with oral cancer at a tertiary care hospital of a third world country. Pakistan J Public Health. 2018;8(3):165\u20139.","journal-title":"Pakistan J Public Health"},{"key":"1571_CR3","first-page":"70","volume":"2","author":"D Goyal","year":"2013","unstructured":"Goyal D, Goyal P, Singh H, Verma C. An update on precancerous lesions of oral cavity. Int J Med Dent Sci. 2013;2:70\u20135.","journal-title":"Int J Med Dent Sci"},{"issue":"2","key":"1571_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.oooo.2015.12.018","volume":"122","author":"RP Ekanayaka","year":"2016","unstructured":"Ekanayaka RP, Tilakaratne WM. Oral submucous fibrosis: review on mechanisms of malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(2):192\u20139.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"1571_CR5","first-page":"58","volume":"6","author":"NP Selvam","year":"2013","unstructured":"Selvam NP, Dayanand AA. Lycopene in the management of oral submucous fibrosis. Asian J Pharm Clin Res. 2013;6(3):58\u201361.","journal-title":"Asian J Pharm Clin Res"},{"issue":"10","key":"1571_CR6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.adaj.2017.07.032","volume":"148","author":"MW Lingen","year":"2017","unstructured":"Lingen MW, Abt E, Agrawal N, Chaturvedi AK, Cohen E, D\u2019Souza G, Gurenlian J, Kalmar JR, Kerr AR, Lambert PM. Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American Dental Association. J Am Dent Assoc. 2017;148(10):712\u201327.","journal-title":"J Am Dent Assoc"},{"issue":"9","key":"1571_CR7","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1074\/mcp.M700520-MCP200","volume":"7","author":"Z Wang","year":"2008","unstructured":"Wang Z, Jiang L, Huang C, Li Z, Chen L, Gou L, Chen P, Tong A, Tang M, Gao F. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics. 2008;7(9):1639\u201350.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"1571_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3329\/bsmmuj.v11i1.35399","volume":"11","author":"MSR Khan","year":"2018","unstructured":"Khan MSR, Siddika F, Xu S, Liu XL, Shuang M, Liang HF. Diagnosing oral squamous cell carcinoma using salivary biomarkers. Bangabandhu Sheikh Mujib Med Univ J. 2018;11(1):1\u201310.","journal-title":"Bangabandhu Sheikh Mujib Med Univ J"},{"key":"1571_CR9","doi-asserted-by":"publisher","first-page":"31520","DOI":"10.1038\/srep31520","volume":"6","author":"S Ishikawa","year":"2016","unstructured":"Ishikawa S, Sugimoto M, Kitabatake K, Sugano A, Nakamura M, Kaneko M, Ota S, Hiwatari K, Enomoto A, Soga T. Identification of salivary metabolomic biomarkers for oral cancer screening. Sci Rep. 2016;6:31520.","journal-title":"Sci Rep"},{"issue":"2","key":"1571_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00784-018-2337-x","volume":"22","author":"J Kaur","year":"2018","unstructured":"Kaur J, Jacobs R, Huang Y, Salvo N, Politis C. Salivary biomarkers for oral cancer and pre-cancer screening: a review. Clin Oral Invest. 2018;22(2):633\u201340.","journal-title":"Clin Oral Invest"},{"issue":"1","key":"1571_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jobcr.2015.08.006","volume":"6","author":"MA Javaid","year":"2016","unstructured":"Javaid MA, Ahmed AS, Durand R, Tran SD. Saliva as a diagnostic tool for oral and systemic diseases. J Oral Biol Craniofac Res. 2016;6(1):67\u201376.","journal-title":"J Oral Biol Craniofac Res"},{"issue":"4","key":"1571_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/0394632015592101","volume":"28","author":"A Santarelli","year":"2015","unstructured":"Santarelli A, Mascitti M, Rubini C, Bambini F, Zizzi A, Offidani A, Ganzetti G, Laino L, Cicci\u00f9 M, Muzio LL. Active inflammatory biomarkers in oral lichen planus. Int J Immunopathol Pharmacol. 2015;28(4):562\u20138.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"1571_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-1","volume":"14","author":"SV von Zeidler","year":"2014","unstructured":"von Zeidler SV, de Souza BT, Mendon\u00e7a EF, Batista AC. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study. BMC Cancer. 2014;14(1):1\u20137.","journal-title":"BMC Cancer"},{"issue":"6","key":"1571_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/jop.12483","volume":"46","author":"S Bazarsad","year":"2017","unstructured":"Bazarsad S, Zhang X, Kim KY, Illeperuma R, Jayasinghe RD, Tilakaratne WM, Kim J. Identification of a combined biomarker for malignant transformation in oral submucous fibrosis. J Oral Pathol Med. 2017;46(6):431\u20138.","journal-title":"J Oral Pathol Med"},{"key":"1571_CR15","doi-asserted-by":"crossref","unstructured":"Choudhry N, Sarmad S, Gondal AJ. Estimation of serum matrix metalloproteinases among patients of oral squamous cell carcinoma. Pakistan J Med Sci. 2019;35(1).","DOI":"10.12669\/pjms.35.1.68"},{"issue":"6","key":"1571_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bjoms.2005.10.005","volume":"44","author":"E Baker","year":"2006","unstructured":"Baker E, Leaper D, Hayter J, Dickenson A. The matrix metalloproteinase system in oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2006;44(6):482\u20136.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"1","key":"1571_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41368-018-0032-z","volume":"11","author":"Y Feng","year":"2019","unstructured":"Feng Y, Li Q, Chen J, Yi P, Xu X, Fan Y, Cui B, Yu Y, Li X, Du Y. Salivary protease spectrum biomarkers of oral cancer. Int J Oral Sci. 2019;11(1):7.","journal-title":"Int J Oral Sci"},{"issue":"8","key":"1571_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.7150\/ijms.25146","volume":"15","author":"KR Bhattarai","year":"2018","unstructured":"Bhattarai KR, Kim H-R, Chae H-J. Compliance with saliva collection protocol in healthy volunteers: strategies for managing risk and errors. Int J Med Sci. 2018;15(8):823\u201331.","journal-title":"Int J Med Sci"},{"issue":"7","key":"1571_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/jso.23302","volume":"107","author":"J Zheng","year":"2013","unstructured":"Zheng J, Chu D, Wang D, Zhu Y, Zhang X, Ji G, Zhao H, Wu G, Du J, Zhao Q. Matrix metalloproteinase-12 is associated with overall survival in Chinese patients with gastric cancer. J Surg Oncol. 2013;107(7):746\u201351.","journal-title":"J Surg Oncol"},{"issue":"2","key":"1571_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/bjc.2013.745","volume":"110","author":"C Kahlert","year":"2014","unstructured":"Kahlert C, Pecqueux M, Halama N, Dienemann H, Muley T, Pfannschmidt J, Lasitschka F, Klupp F, Schmidt T, Rahbari N. Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases. Br J Cancer. 2014;110(2):441.","journal-title":"Br J Cancer"},{"issue":"1","key":"1571_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/1471-2407-14-348","volume":"14","author":"I-C Chung","year":"2014","unstructured":"Chung I-C, Chen L-C, Chung A-K, Chao M, Huang H-Y, Hsueh C, Tsang N-M, Chang K-P, Liang Y, Li H-P. Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma. BMC Cancer. 2014;14(1):348.","journal-title":"BMC Cancer"},{"issue":"1","key":"1571_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/0394632015572557","volume":"28","author":"F Lv","year":"2015","unstructured":"Lv F, Wang J, Wu Y, Chen H, Shen X. Knockdown of MMP12 inhibits the growth and invasion of lung adenocarcinoma cells. Int J Immunopathol Pharmacol. 2015;28(1):77\u201384.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"8","key":"1571_CR23","first-page":"11896","volume":"8","author":"L Liu","year":"2015","unstructured":"Liu L, Sun J, Li G, Gu B, Wang X, Chi H, Guo F. Association between MMP-12-82A\/G polymorphism and cancer risk: a meta-analysis. Int J Clin Exp Med. 2015;8(8):11896.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"1571_CR24","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00405-012-2161-x","volume":"270","author":"JM Kim","year":"2013","unstructured":"Kim JM, Kim HJ, Koo BS, Rha KS, Yoon Y-H. Expression of matrix metalloproteinase-12 is correlated with extracapsular spread of tumor from nodes with metastasis in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013;270(3):1137\u201342.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1571_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fonc.2019.00325","volume":"9","author":"X Zhao","year":"2019","unstructured":"Zhao X, Xu M, Cai Z, Yuan W, Cui W, Li MD. Identification of LIFR, PIK3R1, and MMP12 as novel prognostic signatures in gallbladder cancer using network-based module analysis. Front Oncol. 2019;9:325.","journal-title":"Front Oncol"},{"issue":"2","key":"1571_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.21608\/ejentas.2019.6403.1056","volume":"20","author":"DE-DM El-Hennawi","year":"2019","unstructured":"El-Hennawi DE-DM, El Tabbakh MT, Sabek NAE-A, Abou-halawa AS, Fareed AM. High Mobility Group A2 (HMGA2) and Matrix Metalloproteinase 12 (MMP12) genes expression in Egyptian patients with laryngeal squamous cell carcinoma. Egypt J Ear Nose Throat Allied Sci. 2019;20(2):94\u20138.","journal-title":"Egypt J Ear Nose Throat Allied Sci"},{"issue":"12","key":"1571_CR27","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.prp.2017.09.023","volume":"213","author":"F Han","year":"2017","unstructured":"Han F, Zhang S, Zhang L, Hao Q. The overexpression and predictive significance of MMP-12 in esophageal squamous cell carcinoma. Pathol-Res Pract. 2017;213(12):1519\u201322.","journal-title":"Pathol-Res Pract"},{"key":"1571_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cyto.2018.06.036","volume":"113","author":"SB Holmstr\u00f6m","year":"2019","unstructured":"Holmstr\u00f6m SB, Lira-Junior R, Zwicker S, Majster M, Gustafsson A, \u00c5kerman S, Klinge B, Svensson M, Bostr\u00f6m EA. MMP-12 and S100s in saliva reflect different aspects of periodontal inflammation. Cytokine. 2019;113:155\u201361.","journal-title":"Cytokine"},{"issue":"2","key":"1571_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/2231-0762.155740","volume":"5","author":"SU Rahamthulla","year":"2015","unstructured":"Rahamthulla SU, Priya PV, Hussain SJ, Nasyam FA, Akifuddin S, Srinivas VS. Effectiveness of the supraomohyoid neck dissection in clinically N0 neck patients with squamous cell carcinoma of buccal mucosa and gingivobuccal sulcus. J Int Soc Prevent Commun Dent. 2015;5(2):131.","journal-title":"J Int Soc Prevent Commun Dent"},{"issue":"6","key":"1571_CR30","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1080\/13102818.2014.967510","volume":"28","author":"G Mishev","year":"2014","unstructured":"Mishev G, Deliverska E, Hlushchuk R, Velinov N, Aebersold D, Weinstein F, Djonov V. Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma. Biotechnol Biotechnol Equip. 2014;28(6):1138\u201349.","journal-title":"Biotechnol Biotechnol Equip"},{"issue":"4","key":"1571_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/13547500902829375","volume":"14","author":"C-Y Yen","year":"2009","unstructured":"Yen C-Y, Chen C-H, Chang C-H, Tseng H-F, Liu S-Y, Chuang L-Y, Wen C-H, Chang H-W. Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers. 2009;14(4):244\u20139.","journal-title":"Biomarkers"},{"issue":"1","key":"1571_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/path.1479","volume":"202","author":"U Impola","year":"2004","unstructured":"Impola U, Uitto V-J, Hietanen J, Hakkinen L, Zhang L, Larjava H, Isaka K, Saarialho-Kere U. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol. 2004;202(1):14\u201322.","journal-title":"J Pathol"},{"issue":"4","key":"1571_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/jop.12836","volume":"48","author":"X Cai","year":"2019","unstructured":"Cai X, Yao Z, Liu G, Cui L, Li H, Huang J. Oral submucous fibrosis: a clinicopathological study of 674 cases in China. J Oral Pathol Med. 2019;48(4):321\u20135.","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"1571_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jfma.2017.01.012","volume":"117","author":"S-F Yang","year":"2018","unstructured":"Yang S-F, Wang Y-H, Su N-Y, Yu H-C, Wei C-Y, Yu C-H, Chang Y-C. Changes in prevalence of precancerous oral submucous fibrosis from 1996 to 2013 in Taiwan: a nationwide population-based retrospective study. J Formos Med Assoc. 2018;117(2):147\u201352.","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"1571_CR35","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/jop.12570","volume":"46","author":"PY Yang","year":"2017","unstructured":"Yang PY, Chen YT, Wang YH, Su NY, Yu HC, Chang YC. Malignant transformation of oral submucous fibrosis in Taiwan: a nationwide population-based retrospective cohort study. J Oral Pathol Med. 2017;46(10):1040\u20135.","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"1571_CR36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.oooo.2017.12.011","volume":"125","author":"PM Speight","year":"2018","unstructured":"Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):612\u201327.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"02","key":"1571_CR37","first-page":"275","volume":"26","author":"AH Shaikh","year":"2019","unstructured":"Shaikh AH, Ahmed S, Siddique S, Iqbal N, Hasan SMU, Zaidi SJA, Ali A. Oral submucous fibrosis. Professional Med Jl. 2019;26(02):275\u201381.","journal-title":"Professional Med Jl"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-021-01571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-021-01571-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-021-01571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T12:56:23Z","timestamp":1698929783000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-021-01571-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1571"],"URL":"https:\/\/doi.org\/10.1186\/s12903-021-01571-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-254722\/v1","asserted-by":"object"}]},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"18 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Dow University of health sciences' Institutional Review Board (IRB- 1322\/DUHS\/Approval\/2019\/71). Informed consent to participate was taken from all participants according to Helsinki's declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The consent for publication was taken from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}